SCHEMBL5570541

SCHEMBL5570541

CON=C(c1ccc(NC(=O)C(NC(=O)Nc2ccc(Cl)s2)c2ccccc2)cc1)N(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F10 P00742 2/20 0.39
ALDH1A1 P00352 6/20 0.38
GAA P10253 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
KMT2A Q03164 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
LMNA P02545 1/20 0.37
F7 P08709 1/20 0.37
KDM4E B2RXH2 2/20 0.37
MAPT P10636 1/20 0.37
MMP1 P03956 1/20 0.37
MMP3 P08254 1/20 0.37
FPR2 P25090 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
KLK7 P49862 1/20 0.36
CNR1 P21554 1/20 0.35
HDAC3 O15379 1/20 0.35
HDAC4 P56524 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC7 Q8WUI4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5570537 1.00 F10 (0.39) F10ALDH1A1GAAL3MBTL1KMT2A
SCHEMBL5565727 0.87 F10 (0.38) F10ALDH1A1GAAL3MBTL1KMT2A
SCHEMBL5565730 0.87 F10 (0.38) F10ALDH1A1GAAL3MBTL1KMT2A
SCHEMBL5570620 0.78 F10 (0.39) F10ALDH1A1KMT2ASMN1; SMN2KDM4E
SCHEMBL5570803 0.76 F10 (0.40) F10MMP1MMP3FPR2CNR1
SCHEMBL5570387 0.76 F10 (0.41) F10ALDH1A1GAAKMT2AKDM4E
SCHEMBL5570389 0.75 F10 (0.42) F10ALDH1A1GAAKMT2ASMN1; SMN2
SCHEMBL5567517 0.75 F10 (0.41) F10ALDH1A1GAAKMT2ASMN1; SMN2
SCHEMBL5567519 0.75 F10 (0.41) F10ALDH1A1GAAKMT2ASMN1; SMN2
SCHEMBL3565848 0.74 F10 (0.53) F10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7250415-B2 1,1-Disubstitutedcycloalkyl-, glycinamidyl-, sulfonyl-amidino-, and tetrahydropyrimidinyl-containing diaminoalkyl, β-aminoacids, α-aminoacids and derivatives thereof as factor Xa inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2007-07-31 US disclosed
EP-1628668-A2 1,1-DISUBSTITUTEDCYCLOALKYL-, GLYCINAMIDYL-, SULFONYL-AMIDINO-, AND TETRAHYDROPYRIMIDINYL-CONTAINING DIAMINOALKYL, BETA-AMINOACIDS, ALPHA-AMINOACIDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITO RS Bristol-Myers Squibb Company (US) 2006-03-01 EP disclosed
WO-2004108892-A2 1,1-DISUBSTITUTEDCYCLOALKYL-, GLYCINAMIDYL-, SULFONYL-AMIDINO-, AND TETRAHYDROPYRIMIDINYL-CONTAINING DIAMINOALKYL, β-AMINOACIDS, α-AMINOACIDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2004-12-16 WO disclosed